Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Monitoring potassium levels is important for women taking spironolactone.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Tailored supplementation of calcium, magnesium, and vitamin D based on hair analysis may improve bone health.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Mild skin injury can trigger mineral deposits in rat skin, even without full calciphylactic response.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Epilation and DHT cause skin calcification by increasing ATP and calcium deposits.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.